Mike Cariola brings more than 15 years of industry experience to his role as General Manager and has been a key contributor in leading and transitioning Bode Cellmark to be a world leader within the forensic science community.
Cariola is responsible for the operational leadership of Bode Cellmark’s forensic operations, products, software, and consulting services. In addition to ensuring the quality and reliability of services provided to clients worldwide, Cariola has driven growth through the oversight of Bode Cellmark’s federal business development efforts, active R&D programs, and software and product development.
Cariola has held a variety of progressively responsible positions with the Bode Cellmark predecessor company, Bode Technology. While serving as Laboratory Director, he was primarily involved with Bode Cellmark’s forensic casework and databasing activities. During that time, Bode Technology successfully assisted numerous crime laboratories in the elimination of backlogs and Cariola helped launch several new services and products, implementing new technologies to increase quality, efficiency and effectiveness in the laboratory. These have become the cornerstones of Bode Cellmark’s international offerings and are a significant driver of company growth.
Cariola is a member of numerous professional organizations, including the American Academy of Forensic Sciences, the American Society of Crime Laboratory Directors, the International Association of Chiefs of Police, and the Mid-Atlantic Association of Forensic Sciences. He has also served on the advisory boards of the forensic science programs for Towson University and Virginia Commonwealth University. He holds a master of forensic science degree with a concentration in forensic molecular biology from The George Washington University, and graduated from Cornell University with a bachelor of arts degree in biology.
Director of Operations
Meghan Clement received her master of science in forensic science from the University of New Haven in West Haven, Conn., under the tutelage of Dr. Robert Gaensslen and Dr. Henry Lee. She began her forensic career more than 30 years ago while working for the Albuquerque Police Department Crime Laboratory in the serology section and was also called upon to process crime scenes and analyze blood alcohol samples. During her six years in Albuquerque, she was invited to the FBI Academy as a visiting scientist for three months in 1990 and worked on various RFLP and PCR DNA research projects. She returned from the visiting scientist program and was instrumental in validating RFLP technology and readying the laboratory for DNA testing.
Clement moved to Texas in 1991 and was employed at the Tarrant County Medical Examiner’s Office Crime Laboratory in Fort Worth, where she performed both serology and DNA testing until she took a position at Roche Biomedical Laboratories in Research Triangle Park, NC in late 1994. Roche Biomedical later became Laboratory Corporation of America Holdings, Inc. (LabCorp) after a merger with National Health Laboratories in 1995.
Clement held various director-level positions during her more than 17 years in North Carolina and ultimately became responsible for all aspects of the laboratory. When LabCorp consolidated the Forensic Identity Department in July 2012 after the acquisition of Orchid Cellmark, Clement moved back to Texas as the Senior Director of the newly-branded Cellmark Forensics. She remained an integral member of the management team in Texas and also maintained her technical expertise by performing technical reviews and case consultations.
Clement has testified over 360 times on cases that utilized all DNA technologies including RFLP, DQ Alpha/Polymarker, VNTR, STR, Y-STR and mtDNA.
Director, Sales and Marketing
As the Director, Sales and Marketing for Bode Cellmark, he manages domestic sales efforts and global marketing programs for the company. Other key responsibilities include driving all new program and product launches and developing and managing strategic partnerships.
Singer joined Bode Technology in 2008 and held the role of Sr. Product Manager, with responsibilities of managing product lifecycle of all products offered by Bode Technology to the law enforcement and crime laboratory markets, including developing new product solutions and related requirements, driving internal support and validations, communicating data to the sales and marketing teams, developing strategic product launches, evaluating product costs and setting pricing, and delivering post-launch support and development strategies.
Singer has more than 10 years of experience in product development and management. Prior to joining Bode Technology, Singer held research and product development positions in the biotechnology industry related to vaccine R&D.
Singer earned a master of business administration and a master of science in biotechnology from Johns Hopkins University and a bachelor of science in chemical engineering from the University of Maryland.
Director, Product Research and Development
Jangbir Sangha has been a product development manager for more than 28 years in the in vitro diagnostics and forensic identification industries. He has regulatory knowledge and is experienced in taking a product from conception to ready-to-manufacture under applicable regulatory environments. Sangha is also experienced in unique systems design and development in areas of expertise. He has developed and launched numerous products for Bode Technology including the Bode Buccal DNA Collector and the Bode SecurSwab product lines.
Sangha earned a bachelor of science degree from Panjab University, India, a bachelor of science degree from Wilfrid Laurier University in Waterloo, Canada, and a master of arts from the Meerut University, India. Sangha has more than 20 years of experience in the product development market.
Director, Consulting and Training Services
Manzar Ahmed is a vice president and serves as the Director of Consulting and Training Services for Bode Cellmark. Ahmed brings more than 13 years of management, DNA, and bio-scientific research experience to Bode Cellmark’s professional consulting services.
Bode Cellmark’s team specializes in performing laboratory assessments to evaluate process flows, efficiencies, capacity, capabilities, quality systems, personnel, protocols, and training needs with a focus on meeting international accreditation standards. Ahmed has significant expertise in the development of international laboratories, including the training of management and qualifying analysts to meet international training standards.
Ahmed has played a key role in supporting the President’s National DNA Initiative to reduce DNA backlogs across the United States. Bode Cellmark’s team has been responsible for processing more than 1.5 million DNA databanking samples and Ahmed has successfully led and completed projects for multiple state, federal, and international agencies. In addition, Ahmed also has extensive hands-on experience processing various DNA substrates, implementing robotic methodologies, and effectively using LIMS software for high throughput DNA processing. Ahmed received his master of science in biochemistry and his bachelor of science in biology from The George Washington University.
Senior Scientist/ Laboratory Director
Robert Bever, Ph.D. is a forensic DNA scientist with twenty seven years of research and operational experience. Dr. Bever has served as Laboratory Director for three DNA typing laboratories, has technically reviewed over 40,000 cases and testified in over 150 trials. Additionally Dr. Bever has over twenty years’ experience in analyzing kinship casework to establish parentage, sib-ship, and avuncular relationships. Dr. Bever’s research in human DNA forensics has focused on developing methods to obtain DNA profiles from highly degraded samples, to collect and extract DNA from touched objects, mixture deconvolution using next generation sequencing , and identification geographical origin of material through DNA. Dr. Bever has a Ph. D in Microbiology from University of Maryland and performed post-doctoral research in infectious diseases at the Oregon Health Science University and the University Of Rochester School Of Medicine.
Director, Finance and HR
Director, Applied Research
Director, Forensic Casework
Director, Forensic Casework
Director, Databanking and Human Identification
Director, Validation and Training